- Mapfre reported a net income of EUR 901.6 million for the fiscal year, which surpassed the estimated EUR 890.3 million. This represents a 30% year-over-year increase.
- The company achieved gross written and accepted premiums of EUR 28.12 billion, marking a 4.5% rise from the previous year and exceeding the forecast of EUR 27.84 billion.
- Total revenue for Mapfre reached EUR 33.18 billion, reflecting a 2.9% year-over-year growth.
- Mapfre has increased its final dividend to 9.5 cents gross per share, resulting in a total dividend of 16 cents for 2024.
- Market analysis currently shows 7 ‘buy’ ratings, 2 ‘hold’ ratings, and 5 ‘sell’ ratings for Mapfre’s stocks.
A look at Mapfre SA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Mapfre SA, a company providing insurance services in Europe and the Americas, has garnered positive Smart Scores in various key areas. With a solid Value and Dividend score of 4 each, Mapfre demonstrates strength in these fundamental aspects. Additionally, scoring high in Resilience at 4 and Momentum at an impressive 5, the company shows promising signs of stability and growth potential.
However, the Growth score of 3 suggests a slightly lower outlook for expansion compared to other factors. Despite this, Mapfre SA‘s overall Smart Scores point towards a favorable long-term outlook, underlining its position as a robust player in the insurance industry with strong value, dividends, resilience, and momentum.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
